Search Results - "Gadano, A C"

Chronic hepatitis B: current epidemiology in the Americas and implications for management by Gish, R. G., Gadano, A. C.

“…Hepatitis B virus (HBV) remains a serious health threat in many parts of the world. Although its prevalence is lower in the Americas than in Asia, Africa and…”
Get full text

Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir by Ridruejo, E., Marciano, S., Galdame, O., Reggiardo, M. V., Muñoz, A. E., Adrover, R., Cocozzella, D., Fernandez, N., Estepo, C., Mendizábal, M., Romero, G. A., Levi, D., Schroder, T., Paz, S., Fainboim, H., Mandó, O. G., Gadano, A. C., Silva, M. O.

“…Summary Registration studies show entecavir (ETV) to be effective and safe in NUC‐naïve patients with chronic hepatitis B, but relapse rates after treatment…”
Get full text

Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats by Gadano, Adriaán C., Sogni, Philippe, Yang, Song, Cailmail, Stéphanie, Moreau, Richard, Nepveux, Paul, Couturier, Daniel, Lebrec, Didier

“…Background/Aims: Increased nitric oxide production has been implicated in impaired vascular responsiveness to vasoconstrictors in portal hypertension. However,…”
Get full text

Vascular nitric oxide production during the development of two experimental models of portal hypertension by Gadano, Adrián C., Sogni, Philippe, Heller, Jörg, Moreau, Richard, Bories, Phuong Nhi, Lebrec, Didier

“…Background/Aims: The aim of this study was to determine the relative roles of constitutive NOS (NOS3) and inducible NOS (NOS2) isoforms during the development…”
Get full text

Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources by Marciano, S, Haddad, L, Borzi, S M, D'Amico, C, Gaite, L A, Aubone, M V, Sirotinsky, M E, Ratusnu, N, Frola, M S, Aparicio, M C, Ríos, B, Anselmo, M N, Hansen, R, De Filippi, S, Dans, C García, de Labra, L, Peche, M A, Strella, T M, Ibáñez Duran, M, García Rosales, M B, Dirchwolf, M, Galdame, O A, Gadano, A C

“…To estimate the proportion of patients who access to direct-acting antivirals agents (DAAs) for the treatment of hepatitisC in Argentina and to evaluate…”
Get full text

Use of Liver Grafts From Anti-Hepatitis B Core-Positive Donors: A Multicenter Study in Argentina by Marciano, S, Gaite, L.A, Bisignano, L, Descalzi, V.I, Yantorno, S, Mendizabal, M, Silva, M.O, Anders, M, Orozco, O.F, Traverso, R, Gil, O, Galdame, O.A, Bandi, J.C, de Santibañes, E, Gadano, A.C

“…Abstract Liver transplantation success is limited by the availability of donors. To overcome this limitation, anti-core-positive donors are increasingly being…”
Get full text

Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases by Villamil, Alejandra G, Bandi, Juan C, Galdame, Omar A, Gerona, Solange, Gadano, Adrian C

Get more information

alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen by Gadano, A C, Mosnier, J F, Durand, F, Martinot-Peignoux, M, Marcellin, P, Degott, C, Belghiti, J, Erlinger, S, Benhamou, J P, Bernuau, J R

Get more information

SHORT-TERM, LOW-DOSE THYMOGLOBULINE: THE BEST OPTION TO SPARE CALCINEURIN INHIBITORS IN LIVER TRANSPLANT RECIPIENTS WITH RENAL FAILURE?: 2362 by Casciato, P. C., Marciano, S., Galdame, O. A., Villamil, A. G., Bandi, J. C., de Santibañes, E., Gadano, A. C.

Get full text

A MELD-SCORE BASED LIVER ALLOCATION SYSTEM HAS A NEGATIVE IMPACT ON WAITING LIST MORTALITY AND IS ASSOCIATED WITH LOWER POST-TRANSPLANT SURVIVAL IN A COUNTRY WITH A UNIQUE, LARGE GEOGRAPHIC ORGAN PROCUREMENT AREA: 1029 by Villamil, A. G., Bandi, J. C., Galdame, O. A., Marciano, S., Casciato, P. C., de Santibañes, E., Gadano, A. C.

Get full text

FIRST NATIONAL REPORT AFTER THE IMPLEMENTATION OF THE MELD-BASED ALLOCATION SYSTEM FOR LIVER TRANSPLANTATION IN ARGENTINA: 3001 by McCormack, L., de Santibañes, E., Lendoire, J., Imventarza, O., Gil, O., Toselli, L., Andriani, O., Bisigniano, L., Gadano, A. C.

Get full text

LIVER TRANSPLANTATION IN PATIENTS OVER 65 YEARS: LONG-TERM SURVIVAL AND GRAFT FUNCTION: 386 by Casciato, P. C., Bonacci, M., Surraco, M. P., Orozco, F., Piñero, F., Villamil, A. G., Marciano, S., Bandi, J. C., Galdame, O. A., Gadano, A. C.

Get full text

REPORT OF THE MELD EXCEPTIONS COMMITTEE ACTIVITY IN ARGENTINA: A CRITICAL VIEW: 2992 by McCormack, L., Quiñones, E., Lendoire, J., de Santibañes, E., Andriani, O., Imventarza, O., Gil, O., Toselli, L., Gondolesi, G., Bisigniano, L., Gadano, A. C.

Get full text

MELD PRIORITIZATION FOR PATIENTS WITH CIRRHOSIS AND SMALL UNRESECTABLE HEPATOCELLULAR CARCINOMA HAS A MORE POSITIVE IMPACT IN WAITING TIME AND POST TRANSPLANT RECURRENCE FREE SURVIVAL THAN LIVING DONOR LIVER TRANSPLANTATION: 618 by Villamil, A G., Galdame, O A., Bandi, J C., Casciato, P C., Reig, M, Ardiles, V, de Santibañes, E, Gadano, A C.

Get full text

Imatinib-induced fatal acute liver failure by Ridruejo, Ezequiel, Cacchione, Roberto, Villamil, Alejandra G, Marciano, Sebastián, Gadano, Adrián C, Mandó, Oscar G

“…Imatinib mesylate is a drug that has been approved for treatment of chronic myeloid leukemia （CML） in blast crisis, accelerated or chronic phase, and also for…”
Get full text

Hepatitis C in Argentina: epidemiology and treatment by Gaite, Luis Alejandro, Marciano, Sebastián, Galdame, Omar Andrés, Gadano, Adrián Carlos

“…Hepatitis C is the leading cause of chronic hepatitis, cirrhosis, and liver cancer in Argentina, where from 1.5% to 2.5% of adults are infected. Most of the…”
Get full text

Ketoprofen and aseptic meningitis by Roel, J E, Gadano, A C, Falcón, J L

Get more information

Pre-treatment prediction of response to peginterferon plusribavirin in chronic hepatitis C genotype 3 by Sebastián Marciano Silvia M Borzi Melisa Dirchwolf Ezequiel Ridruejo Manuel Mendizabal Fernando Bessone María E Sirotinsky Diego H Giunta Julieta Trinks Pablo A Olivera Omar A Galdame Marcelo OSilva Hugo A Fainboim Adrián C Gadano

“…AIM： To evaluate pre-treatment factors associatedwith sustained virological response （SVR） in patientswith hepatitis C virus （HCV） genotype 3 treated…”
Get full text